James G. Herman
0000-0001-8102-1740
Publication & Citation Trends
Publications
0 total
Lnc5q21.2, a novel long intergenic RNA, sensitizes colorectal cancer cells to ATR inhibitor by activating Wnt pathway
Cited by 1
Semantic Scholar
Abstract 6361: The vanguard study: An NCI cancer screening research network feasibility study
Cited by 0
Semantic Scholar
De Novo high-volume metastatic prostate cancer with primary resistance to standard systemic therapy and exceptional response to PSMA-Lu177: A case report
Cited by 0
Semantic Scholar
Methylation of FAM110C is a synthetic lethal marker for ATR/CHK1 inhibitors in pancreatic cancer
Cited by 23
Semantic Scholar
Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling OA
Cited by 2
Semantic Scholar
Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients
Cited by 3
Semantic Scholar
Neighborhood-level deprivation and survival in lung cancer OA
Cited by 5
Semantic Scholar
Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancer
Cited by 10
Semantic Scholar
Research Topics
Epigenetics and DNA Methylation
(562)
Cancer-related gene regulation
(197)
RNA modifications and cancer
(161)
Cancer Genomics and Diagnostics
(111)
Histone Deacetylase Inhibitors Research
(93)
Affiliations
Ontario Institute for Cancer Research
Universitat Autònoma de Barcelona
University of Maryland, Baltimore
National Institutes of Health
Lovelace Respiratory Research Institute